A Conversation With Ceo Paul Hudson Of Sanofi Mckinsey January 11, 2023 | interview. (5 pages) since joining sanofi in 2019, ceo paul hudson has seen nine consecutive quarters of growth and more than a dozen acquisitions and business development deals, including mrna therapeutics company translate bio and biotech company kadmon. next year, sanofi expects to have the first broadly protective option. Under ceo paul hudson, french european pharmaceutical company sanofi is seeking to shape this transition; pursuing global leadership in scientific innovation, and the use of digital technology and data to transform the practice of medicine.
Coming Together To Fight Covid 19 A Conversation With Paul Hudson Ceo Pharma fireside chat between paul hudson, ceo of sanofi and david flores, ceo at biocentury china our community is about connecting people through open and thoughtful conversations. we want. ‘stay grounded, stay humble’: sanofi ceo paul hudson january 11, 2023 in the wake of the covid 19 pandemic, one of the first non french leaders of the pharmaceutical company sanofi explains cultural transformations, the growth of ai in decision making, and how he stays humble. I speak with sanofi ceo paul hudson about how artificial intelligence is changing the pharma industry, and about his leadership journey. Sanofi ceo paul hudson joins 'squawk box' to discuss the company's plan to become an immunology powerhouse, drug pipeline outlook, using ai for future drug d.
Comments are closed.